Ministerial Regulation No. 39 of 2018 on Procedures for Compulsory Patent Licensing took effect on 28 December 2018. This Regulation appears intended to provide a clear structure to compulsory licensing in accordance with TRIPS/the Doha Declaration. However it goes beyond that for reasons unknown so has caused an uproar in the pharma world.
Subscribe to the RSS newsfeed notifications of the latest free Helpdesk resources and events. You can also follow us on Twitter, Facebook and LinkedIn to keep up to date.